DYN
Dyne Therapeutics, Inc.
Stock
$15.20−0.62 (−3.92%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$478M | −$403M | −$292M | −$188M | −$154M | −$120M | −$47M | −$12M |
| Capital expenditures | $2.6M | $1.9M | $2.4M | $729K | $3.1M | $3.6M | $1.2M | $1.6M |
| Free cash flow | −$480M | −$405M | −$295M | −$189M | −$157M | −$123M | −$48M | −$13M |
| Stock-based compensation | $50M | $46M | $46M | $20M | $15M | $18M | $6.6M | $26K |